| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Ms. Phyllis R. YaleIndependent Director | -5.04k | 0.00 | Other Disposition | - | 9.53k | -34.59% |
| 2026-05-14 | Mr. James O. HeartyCCO | -5.78k | 500.01k | Derivative Exercise and Sale | 110.63 - 198.10 | 13.91k | - |
| 2026-05-15 | Mr. James O. HeartyCCO | -13.56k | 2.63M | 売り | 193.98 | 13.91k | -49.38% |
| 2026-05-11 | Mr. David P. MaughanCOO of DaVita Kidney Care | -20.53k | 4.09M | 売り | 199.15 - 199.25 | 26.72k | -43.45% |
| 2026-05-07 | Mr. Joel AckermanCFO & Treasurer | -51.47k | 9.89M | 売り | 192.10 | 97.92k | -34.45% |
| 2026-05-06 | Mr. James O. HeartyCCO | -2.18k | 381.92k | 売り | 174.87 | 27.47k | -7.36% |
| 2026-05-01 | Berkshire Hathaway Inc.法人 | -1.22M | 182.86M | 売り | 149.84 | 28.88M | -4.05% |
| 2026-03-15 | Mr. David P. MaughanCOO of DaVita Kidney Care | -13.11k | 1.98M | Sale to Issuer | 150.72 | 47.08k | -21.78% |
| 2026-03-15 | Mr. James O. HeartyCCO | -11.58k | 1.75M | Sale to Issuer | 150.72 | 29.65k | -28.08% |
| 2026-03-15 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -33.86k | 5.10M | Sale to Issuer | 150.72 | 101.84k | -24.95% |
| 2026-03-15 | Mr. Joel AckermanCFO & Treasurer | -42.82k | 6.45M | Sale to Issuer | 150.72 | 149.39k | -22.28% |
| 2026-02-06 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | 1.36k | 148.58k | Derivative Exercise and Retained Stock | 108.93 | 68.35k | 2.04% |
| 2026-02-06 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -6.72k | 270.55k | Derivative Exercise and Sale | 108.93 - 149.22 | 68.35k | - |
| 2026-02-06 | Mr. Joel AckermanCFO & Treasurer | 6.80k | 740.40k | Derivative Exercise and Retained Stock | 108.93 | 107.79k | 6.73% |
| 2026-02-06 | Mr. Joel AckermanCFO & Treasurer | -37.27k | 1.50M | Derivative Exercise and Sale | 108.93 - 149.22 | 107.79k | - |
| 2026-01-29 | Berkshire Hathaway Inc.法人 | -1.66M | 199.94M | 売り | 120.56 | 30.10M | -5.22% |
| 2025-12-04 | Mr. James O. HeartyCCO | 260.00 | 28.32k | Derivative Exercise and Retained Stock | 108.93 | 15.26k | 1.73% |
| 2025-12-04 | Mr. James O. HeartyCCO | -5.62k | 52.33k | Derivative Exercise and Sale | 108.93 - 118.25 | 15.26k | - |
| 2025-11-15 | Mr. Javier J. RodriguezCEO & Executive Director | -5.17k | 627.81k | Sale to Issuer | 121.55 | 845.14k | -0.61% |
| 2025-10-27 | Berkshire Hathaway Inc.法人 | -401.51k | 54.35M | 売り | 135.36 | 31.76M | -1.25% |
| 2025-09-22 | Mr. David P. MaughanCOO of DaVita Kidney Care | -7.50k | 976.33k | Sale to Issuer | 130.16 | 30.23k | -19.88% |
| 2025-07-31 | Berkshire Hathaway Inc.法人 | -1.64M | 230.02M | 売り | 140.61 | 32.16M | -4.84% |
| 2025-07-23 | Mr. James O. HeartyCCO | -2.35k | 352.65k | Automatic Disposition | 150.00 | 15.00k | -13.55% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。